<?xml version="1.0" encoding="UTF-8"?>
<p id="par0245">The content of this guideline has been separated in to two sections. The first part encompasses the supply of CCP and the second part provides the clinical use of CCP for the treatment of patients with severe COVID-19 infection.</p>
